Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The antidepressant agomelatine is a MT(1)/MT(2) receptor agonist and 5-HT(2C) antagonist. Its antidepressant activity is proposed to result from the synergy between these sets of receptors. Agomelatine-induced changes in the brain have been reported under basal conditions. Yet, little is known about its effects in the brain exposed to chronic stress as a risk factor for major depressive disorder. Recently, we described agomelatine-induced changes on neuronal activity and adult neurogenesis in the hippocampus of rats subjected to chronic footshock stress. In order to better characterize the actions of agomelatine in the stress-compromised brain, here we investigated its effects on hippocampal neurogenesis in the chronic mild stress (CMS) model. Adult male rats were subjected to various mild stressors for 5 weeks, and treated with agomelatine during the last 3 weeks of the stress period. The sucrose preference test was performed weekly to measure anhedonia, and the marble burying test was carried out at the end of the experiment to assess anxiety-like behavior. In our model, the CMS paradigm did not change sucrose preference; however, it increased marble burying behavior, indicating enhanced anxiety. Interestingly, this stress model differentially affected distinct stages of the neurogenesis process. Whereas CMS did not influence the rate of hippocampal cell proliferation, it significantly decreased the newborn cell survival and doublecortin expression in the dentate gyrus. Importantly, treatment with agomelatine completely normalized stress-affected cell survival and partly reversed reduced doublecortin expression. Taken together, these data show that agomelatine has beneficial effects on hippocampal neurogenesis in the CMS paradigm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 1×
“…granular cell layer; GR, glucocorticoid receptor; GSK3 , glycogen synthase inase 3 ; HEC, hydroxyethylcellulose; ir, immunoreactivity; MR, mineralocortioid receptor; MT, melatonin receptor; NRI, noradrenaline reuptake inhibitor; OD, ptical density; SGZ, subgranular zone; SNRI, serotonin and…”
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993 · cited 1×
“The CMS protocol was adapted from previous studies [10,36].”
Dissecting components of reward: ‘liking’, ‘wanting’, and learning
Berridge, K. C., Robinson, T. E., & Aldridge, J. W. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.014 · Cited by 1,942
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832 · cited 1×
“Treatment of depressive Abbreviations: 5-HT, serotonin; Ago, agomelatine; Akt, protein kinase B; BrdU, romodeoxyuridine; BDNF, brain-derived neurotrophic factor; CMS, chronic mild tress; CREB, cyclic adenosine monophosphate responsive element binding protein; TR, control group; DCX, doublecortin;…”
Willner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605
New approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 2×
“However, since effects of antidepressant drugs might differ in disturbed versus intact systems [6], the latter findings under basal conditions are not possible to directly extrapolate to the therapeutic action of agomelatine in depression.”
Chronic mild stress-induced anhedonia: A realistic animal model of depression
Willner, P., Muscat, R., & Papp, M. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80194-0 · Cited by 1,160 · cited 1×
“The chronic mild stress (CMS) paradigm has been proposed as an animal model of depression [25].”
“Liking” and “wanting” food rewards: Brain substrates and roles in eating disorders
Berridge, K. C. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.02.044 · Cited by 1,147
IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress
Koo, J. W., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708092105 · Cited by 862
VEGF links hippocampal activity with neurogenesis, learning and memory
Cao, L., Jiao, X., Zuzga, D. S., Liu, Y., Fong, D. M., Young, D., & During, M. J. (2004) · Nature Genetics · doi:10.1038/ng1395 · Cited by 850
Role of neurotrophic factors in depression
CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667 · cited 1×
“…cyclic adenosine monophosphate responsive element binding protein; TR, control group; DCX, doublecortin; ERK1/2, extracellular signal-regulated kinase /2; GCL, granular cell layer; GR, glucocorticoid receptor; GSK3 , glycogen synthase inase 3 ; HEC, hydroxyethylcellulose; ir, immunoreactivity; MR,…”
Research and treatment approaches to depression
Wong, M.-L., & Licinio, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072566 · Cited by 656
Fluoxetine targets early progenitor cells in the adult brain
Encinas, J. M., Vaahtokari, A., & Enikolopov, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601992103 · Cited by 637
Bessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.119 · Cited by 598
Anhedonia and motivational deficits in rats: Impact of chronic social stress
Rygula, R., Abumaria, N., Flügge, G., Fuchs, E., Rüther, E., & Havemann-Reinecke, U. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.03.009 · Cited by 554
Do animal models of anxiety predict anxiolytic-like effects of antidepressants?
Borsini, F., Podhorna, J., & Marazziti, D. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1155-6 · Cited by 347
Goodwin, G. M., Emsley, R., Rembry, S., Rouillon, F., & the Agomelatine Study Group (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04548 · Cited by 340
Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis
Banasr, M., Soumier, A., Hery, M., Mocaër, E., & Daszuta, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.025 · Cited by 318
Grønli, J., Bramham, C., Murison, R., Kanhema, T., Fiske, E., Bjorvatn, B., Ursin, R., & Portas, C. M. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.11.021 · Cited by 260
Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia
Grippo, A. J., Francis, J., Beltz, T. G., Felder, R. B., & Johnson, A. K. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.02.011 · Cited by 233
The economic burden of depression in the US: societal and patient perspectives
Greenberg, P. E., & Birnbaum, H. G. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.3.369 · Cited by 166 · cited 1×
“Depression is a devastating illness and a major contributor to the global disease burden [1,2].”
Païzanis, E., Renoir, T., Lelievre, V., Saurini, F., Melfort, M., Gabriel, C., Barden, N., Mocaër, E., Hamon, M., & Lanfumey, L. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990514 · Cited by 123
Self-citation(1995) · doi:10.1097/00008877-199505001-00026 · Cited by 119
Effect of Chronic Stress on Synaptic Currents in Rat Hippocampal Dentate Gyrus Neurons
Karst, H., & Joëls, M. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00691.2002 · Cited by 111
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm
Farley, S., Apazoglou, K., Witkin, J. M., Giros, B., & Tzavara, E. T. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709991076 · Cited by 96
Stout, S. C., Mortas, P., Owens, M. J., Nemeroff, C. B., & Moreau, J.-L. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00412-x · Cited by 94
Cited by
Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects
Mahar, I., Bambico, F. R., Mechawar, N., & Nobrega, J. N. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.009 · Cited by 694
Dendritic spines: Revisiting the physiological role
Chidambaram, S. B., Rathipriya, A. G., Bolla, S. R., Bhat, A., Ray, B., Mahalakshmi, A. M., Manivasagam, T., Thenmozhi, A. J., Essa, M. M., Guillemin, G. J., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.005 · Cited by 255
Sex differences in the antidepressant-like effects of ketamine
Carrier, N., & Kabbaj, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.12.009 · Cited by 251
“Sucrose preference test The sucrose preference test consisted of a two-bottle choice paradigm (Carrier and Kabbaj, 2012a; Chen et al., 2012; Dagyte et al., 2011; Kentner et al., 2010).”
MethodPetrik, D., Lagace, D. C., & Eisch, A. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.003 · Cited by 241
Guardiola‐Lemaitre, B., De Bodinat, C., Delagrange, P., Millan, M. J., Munoz, C., & Mocaër, E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12720 · Cited by 182
Self-citation
Metadata
- Authors
- Dagytė, G., Crescente, I., Postema, F., Seguin, L., Gabriel, C., Mocaër, E., Boer, J. A. D., & Koolhaas, J. M.
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 218
- Issue
- 1
- Pages
- 121-128
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W1964209299
- Cited by
- 69
- References
- 26
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.